Integral Global

Email

hassan@integralglobal.net

Phone

+92512726952

Web

https://www.integralglobal.net/

Address

Office 211(B), Second Floor, Evacuee Trust Complex, Aga Khan Road, F-5/1 Adjacent to Marriott Hotel Islamabad Islamabad, 44000 Pakistan
About Integral Global

 Integral Global Health is a 501(c)3 organization that works with Ministries and other governmental institutions in Eastern Europe and South and Central Asia. Our team has extensive knowledge of in-country operations through a variety of mechanisms that allow us to support partners in achieving goals. Over the last six years, Integral Global Health has had extensive impact coordinating and implementing public health programs, including opening the first Emergency Operations Center in the Republic of Uzbekistan, conducting a nation-wide serosurvey on hepatitis B, C and COVID-19, and providing infrastructure development for capacity building programs. Currently, IGH serves as the main implementing partner for the Centers for Disease Control and Prevention’s (CDC) polio eradication initiative. IGH manages the National Stop Transmission of Polio (NSTOP) and responded to the 2022 floods in Sindh, funded by the Bill and Melinda Gates Foundation. IGH effectively manages coordination between government and non-governmental partners to bring resources where they are most needed. Integral Global, has been at the forefront of hepatitis elimination efforts in Pakistan for several years. They have established strong partnerships with national and provincial health departments, governments, and international organisations, including the World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC).
Their key contributions to hepatitis elimination in Pakistan include:
1. Formulation of the National Technical Advisory Group (TAG)
2. Development of the National Hepatitis Strategic Framework (NHSF

  1. Development of Provincial Hepatitis Action Plans: They have worked closely with provincial governments to develop hepatitis action plans, ensuring the smooth implementation of the NHSF at the grassroots level. These plans are tailored to the specific needs and contexts of each province.
    4. Development of National Hepatitis Testing and Treatment Guidelines
    5. Prime Minister’s National Initiative for Hepatitis C Elimination
    6. Strategic Partnerships with International Partners
    7. Presenting their work at International Forums: They have presented their work at numerous international forums, including the World Hepatitis Summit, International Viral Hepatitis Elimination Meetings, EASL meetings, and the Global Hepatitis Summit. Their Country Lead was recognised as one of the top five presenters at the World Hepatitis Summit 2024 in Portugal.

Through these efforts, Integral Global has demonstrated its commitment to hepatitis elimination in Pakistan, working collaboratively with governments, international partners, and communities to achieve a hepatitis-free future.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close